Nimodipine

Overview

Nimodipine is a calcium channel blocker primarily used to reduce brain damage caused by a lack of oxygen brought on by bleeding from a burst blood vessel. It works by relaxing narrowed blood vessels in the brain, facilitating improved blood flow.

API suppliers (4)

Suppliers of Nimodipine backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• LUSOCHIMICA SPAItaly1 active DMF
• LUSOCHIMICA SPAItaly1 active DMF
• BAYER HEALTHCARE AG
• USV LTD

Patent & exclusivity (US)

Per the FDA Orange Book (6 approved US products), the latest listed US patent on Nimodipine expires 15 Apr 2038. Generic API sourcing typically opens up once these lapse.

Therapeutic areas